Andrew J. Oakley was elected to the Board of Directors in 2019 and is regarded as an independent board member.
Andrew is a global executive with more than 20 years of financial and capital markets experience, holding positions as Chief Financial Officer of Actelion, Vectura PLC, Sosei Group Corporation and Autolus Therapeutics PLC.
Andrew currently serves as Chief Financial Officer of Theolytics Ltd. and is also a board member of Novaremed AG.
Andrew holds a Bachelor of Economics degree from Macquarie University and an MBA from London Business School, United Kingdom. Andrew has been a member of the Australian Institute of Chartered Accountants since 1987.